Michael Reardon, M.D.

Neurology with Special Qualification in Child Neurology

Where I Practice:

Pediatrix Specialty Care of Austin

About

Michael Reardon, M.D., graduated from the University of Oklahoma in 1993 and earned their medical degree from the University of Colorado Health Sciences Center in 1997. They completed their residency in neurology in 2001, serving as chief resident from 2000-2001 at the University of Iowa. Dr. Reardon continued at Iowa as a pediatric resident and completed child neurology training in July 2003.

From there, Dr. Reardon returned to their original home state of Texas, first working at Driscoll Children’s Hospital in Corpus Christi before coming to Austin in 2005 to join Specially for Children. In 2010, they helped establish and lead the Dell Children’s Medical Center Concussion Clinic. Dr. Reardon also served as co-director of the Pediatric Muscular Dystrophy Association Clinic for several years. Dr. Reardon was one of the founding partners of Child Neurology Consultants of Austin (CNCA), which was formed in 2016 and is now Pediatrix Specialty Care of Austin. Dr. Reardon currently serves as director of general child neurology for the practice.

Education and Training

Professional School: University of Colorado School of Medicine, 1997

Residency: Univ of Iowa Hosps & Clinics, 2002

Fellowship: University of Iowa Hospitals and Clinics, 2003
Board Specialities: American Board of Psychiatry & Neurology - Psychiatry & Neurology, Neurology with Special Qualifications in Child Neurology
Affiliations

Texas A&M College of Medicine, Faculty Member

A pediatric neurology specialty requires at least five years of training following graduation from medical school. There are several pathways to train. Our program is unique in that we allow all five years to be completed at Pediatrix® Specialty Care of Austin. We believe doing so offers residents the opportunity to build relationships with patients and families, which is an essential aspect for delivering high-quality care.
News

In the news Healthline

ADHD Medication Errors for Young People on the Rise

A new study published in Pediatrics found that errors in attention-deficit/hyperactivity disorder (ADHD) medications have risen nearly 300% in the past two decades among people under the age of 20.
Sep 19, 2023

In the news Healthline

ADHD Medications and Youth Substance Abuse Risk

A new study published in JAMA Psychiatry has found that youth who are prescribed stimulants to treat their ADHD are not more likely to become addicted to drugs later in life.
Jul 5, 2023